Pharmasset Initiates Multiple Ascending Dose Study Of R7128 In Patients Chronically Infected With HCV Genotype 1

Thu, 01 Mar 2007 02:00 PM EST

... Pharmasset initiated the multiple ascending dose portion of an on-going Phase 1 clinical trial evaluating R7128 in up to 40 patients chronically infected with hepatitis C virus (HCV) genotype 1. [click link for full article] ...